S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ALLR Allarity Therapeutics Inc

1.015

-0.025 (-2.40%)

Dec 24 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Allarity Therapeutics Charts.

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Allarity Therapeutics Charts.

Allarity Therapeutics Inc News

Form 8-K - Current report
Tuesday 19 November 2024 (1 month ago) • Edgar (US Regulatory)

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
Monday 18 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights
Thursday 14 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 23 October 2024 (2 months ago) • Edgar (US Regulatory)

Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib
Tuesday 22 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 11 October 2024 (2 months ago) • Edgar (US Regulatory)

Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement
Thursday 10 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 4 October 2024 (3 months ago) • Edgar (US Regulatory)

Allarity Therapeutics Strengthens Leadership with Key Appointments to Accelerate Stenoparib PARP Inhibitor Program
Thursday 3 October 2024 (3 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 1 October 2024 (3 months ago) • Edgar (US Regulatory)

More Allarity Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions